An overview of Influenza A virus receptors

Critical Reviews in Microbiology

Volumn 37, Issue 2, 2011, Pages 157-165

  Ge, Shengqiang ^a,b   Wang, Zhiliang ^b  

^a YANGZHOU UNIVERSITY   (China)

^b National Reference Laboratory for Newcastle Disease   (China)

Author keywords

Influenza A virus; receptors; Sialic acid

Indexed keywords

AMANTADINE; OSELTAMIVIR; RIMANTADINE; SIALIC ACID; VIRUS HEMAGGLUTININ; VIRUS RECEPTOR; ZANAMIVIR;

ANIMAL DISEASE; APE; CAT; CHICKEN; CHLOROCEBUS; DOG; DUCK; FERRET; HORSE; HUMAN; INFLUENZA A; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; QUAIL; REVIEW; RODENT; SWINE; VIRUS CLASSIFICATION;

ANIMALS; BIRDS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTORS, VIRUS;

INFLUENZA A VIRUS;

EID: 79953893978     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2010.536523     Document Type: Review

References (123)

1. Auewarakul P, Suptawiwat O, Kongchanagul A, Sangma C, Suzuki Y, Ungchusak K, Louisirirotchanakul S, Lerdsamran H, Pooruk P, Titithanyanont A, Pittayawonganon C, Guo CT, Hiramatsu H, Jampangern W, Chunsutthiwat S, Puthavathana P. (2007). An avian infuenza H5N1 virus that binds to a human-type receptor. J Virol, 81, 9950-5. (Pubitemid 350067698)
2. Baranowski E, Ruiz-Jarabo CM, Domingo E. (2001). Evolution of cell recognition by viruses. Science, 292, 1102-5. (Pubitemid 32440921)
3. Barnard DL. (2009). Animal models for the study of infuenza pathogenesis and therapy. Antiviral Res, 82, A110-22.
4. Baum LG, Paulson JC. (1990). Sialyloligosaccharides of the respiratory epithelium in the selection of human infuenza virus receptor specifcity. Acta Histochem Suppl, 40, 35-8.
5. Belser JA, Blixt O, Chen LM, Pappas C, Maines TR, Van Hoeven N, Donis R, Busch J, McBride R, Paulson JC, Katz JM, Tumpey TM. (2008). Contemporary North American infuenza H7 viruses possess human receptor specifcity: Implications for virus transmissibility. Proc Natl Acad Sci USA, 105, 7558-63. (Pubitemid 351830057)
6. Blix FG, Gottschalk A, Klenk E. (1957). Proposed nomenclature in the feld of neuraminic and sialic acids. Nature, 179, 1088.
7. Blix G, Svennerholm L, Werner I. (1952). The isolation of chondrosamine from gangliosides and from submaxillary mucin. Acta chem. scand, 6, 358-62.
8. Bright RA, Medina M-j Xu, X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov AI. (2005). Incidence of adamantane resistance among infuenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. The Lancet, 366, 1175-81. (Pubitemid 41393595)
9. Burmeister WP, Guilligay D, Cusack S, Wadell G, Arnberg N. (2004). Crystal Structure of Species D Adenovirus Fiber Knobs and Teir Sialic Acid Binding Sites. J. Virol., 78, 7727-36. (Pubitemid 38915919)
10. Butler D. (2006). Alarms ring over bird fu mutations. Nature, 439, 248-9.
11. Carlescu I, Scutaru D, Popa M, Uglea C. (2009). Synthetic sialic-acid-containing polyvalent antiviral inhibitors. Med Chem Res 18, 477-94.
12. Chandrasekaran A, Srinivasan A, Raman R, Viswanathan K, Raguram S, Tumpey TM, Sasisekharan V, Sasisekharan R. (2008). Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol, 26, 107-13.
13. Chappell JD, Prota AE, Dermody TS, Stehle T. (2002). Crystal structure of reovirus attachment protein [sigma]1 reveals evolutionary relationship to adenovirus fber. EMBO J, 21, 1-11. (Pubitemid 34087069)
14. Check E. (2005). Avian fu special: is this our best shot? Nature, 435, 404-6. (Pubitemid 40734217)
15. Childs RA, Palma AS, Wharton S, Matrosovich T, Liu Y, Chai W, Campanero-Rhodes MA, Zhang Y, Eickmann M, Kiso M, Hay A, Matrosovich M, Feizi T. (2009). Receptor-binding specifcity of pandemic infuenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol, 27, 797-9.
16. Chou HH, Hayakawa T, Diaz S, Krings M, Indriati E, Leakey M, Paabo S, Satta Y, Takahata N, Varki A. (2002). Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution. Proc Natl Acad Sci USA, 99, 11736-41. (Pubitemid 34994468)
17. Chu VC, Whittaker GR. (2004). Infuenza virus entry and infection require host cell N-linked glycoprotein. Proc Natl Acad Sci USA, 101, 18153-8. (Pubitemid 40054089)
18. Daly JM, Blunden AS, Macrae S, Miller J, Bowman SJ, Kolodziejek J, Nowotny N, Smith KC. (2008). Transmission of equine infuenza virus to English foxhounds. Emerg Infect Dis, 14, 461-4. (Pubitemid 351451395)
19. De Lima MC, Ramalho-Santos J, Flasher D, Slepushkin VA, Nir S, Duzgunes N. (1995). Target cell membrane sialic acid modulates both binding and fusion activity of infuenza virus. Biochim Biophys Acta, 1236, 323-30.
20. Dimitrov DS. (2004). Virus entry: molecular mechanisms and biomedical applications. Nat Rev Microbiol, 2, 109-22. (Pubitemid 39490065)
21. Drinka PJ, Haupt T. (2007). Emergence of rimantadine-resistant virus within 6 days of starting rimantadine prophylaxis with oseltamivir treatment of symptomatic cases. J Am Geriatr Soc, 55, 923-6. (Pubitemid 47011032)
22. Fauci AS. (2006). Emerging and Re-Emerging Infectious Diseases: Infuenza as a Prototype of the Host-Pathogen Balancing Act. Cell, 124, 665-70. (Pubitemid 43261439)
23. Fazekas De St Groth S. (1948). Viropexis, the mechanism of infuenza virus infection. Nature, 162, 294.
24. Gagneux P, Varki A. (1999). Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology, 9, 747-55. (Pubitemid 29376001)
25. Gambaryan A, Webster R, Matrosovich M. (2002). Diferences between infuenza virus receptors on target cells of duck and chicken. Arch Virol, 147, 1197-208. (Pubitemid 34592888)
26. Gambaryan A, Yamnikova S, Lvov D, Tuzikov A, Chinarev A, Pazynina G, Webster R, Matrosovich M, Bovin N. (2005a). Receptor specifcity of infuenza viruses from birds and mammals: new data on involvement of the inner fragments of the carbohydrate chain. Virology, 334, 276-83. (Pubitemid 40386961)
27. Gambaryan AS, Boravleva EY, Matrosovich TY, Matrosovich MN, Klenk HD, Moiseeva EV, Tuzikov AB, Chinarev AA, Pazynina GV, Bovin NV. (2005b). Polymer-bound 6′ sialyl-N-acetyllactosamine protects mice infected by infuenza virus. Antiviral Res, 68, 116-23. (Pubitemid 41612455)
28. Gambaryan AS, Tuzikov AB, Bovin NV, Yamnikova SS, Lvov DK, Webster RG, Matrosovich MN. (2003). Diferences between infuenza virus receptors on target cells of duck and chicken and receptor specifcity of the 1997 H5N1 chicken and human infuenza viruses from Hong Kong. Avian Dis, 47, 1154-60. (Pubitemid 37143905)
29. Gambaryan AS, Tuzikov AB, Pazynina GV, Desheva JA, Bovin NV, Matrosovich MN, Klimov AI. (2008). 6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 infuenza viruses of terrestrial poultry. Virol J, 5, 85.
30. Gamblin SJ, Haire LF, Russell RJ, Stevens DJ, Xiao B, Ha Y, Vasisht N, Steinhauer DA, Daniels RS, Elliot A, Wiley DC, Skehel JJ. (2004). The structure and receptor binding properties of the 1918 infuenza hemagglutinin. Science, 303, 1838-42. (Pubitemid 38374870)
31. Glaser L, Conenello G, Paulson J, Palese P. (2007). Efective replication of human infuenza viruses in mice lacking a major alpha2,6 sialyltransferase. Virus Res, 126, 9-18. (Pubitemid 46726689)
32. Govorkova E, Murti G, Meignier B, de Taisne C, Webster R. (1996). African green monkey kidney (Vero) cells provide an alternative host cell system for infuenza A and B viruses. J Virol, 70, 5519-24. (Pubitemid 26240727)
33. Guan Y, Shortridge KF, Krauss S, Webster RG. (1999). Molecular characterization of H9N2 infuenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? Proc Natl Acad Sci USA, 96, 9363-7. (Pubitemid 29374760)
34. Gubareva LV, Matrosovich MN, Brenner MK, Bethell RC, Webster RG. (1998). Evidence for zanamivir resistance in an immunocompromised child infected with infuenza B virus. J Infect Dis, 178, 1257-62.
35. Guo CT, Takahashi N, Yagi H, Kato K, Takahashi T, Yi SQ, Chen Y, Ito T, Otsuki K, Kida H, Kawaoka Y, Hidari KI, Miyamoto D, Suzuki T, Suzuki Y. (2007). The quail and chicken intestine have sialyl-galactose sugar chains responsible for the binding of infuenza A viruses to human type receptors. Glycobiology, 17, 713-24. (Pubitemid 47050660)
36. Guo CT, Takahashi T, Bukawa W, Takahashi N, Yagi H, Kato K, Hidari KI, Miyamoto D, Suzuki T, Suzuki Y. (2006). Edible bird's nest extract inhibits infuenza virus infection. Antiviral Res, 70, 140-6. (Pubitemid 44226306)
37. Harford CG, Hamlin A. (1952). Efect of infuenza virus on cilia and epithelial cells in the bronchi of mice. J Exp Med, 95, 173-90.
38. Hartshorn KL, White MR, Mogues T, Ligtenberg T, Crouch E, Holmskov U. (2003). Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against infuenza A viruses. Am J Physiol Lung Cell Mol Physiol, 285, L1066-76. (Pubitemid 37310096)
39. Hatta M, Hatta Y, Kim JH, Watanabe S, Shinya K, Nguyen T, Lien PS, Le QM, Kawaoka Y. (2007). Growth of H5N1 infuenza A viruses in the upper respiratory tracts of mice. PLoS Pathog, 3, 1374-9. (Pubitemid 350085602)
40. Hidari KI, Shimada S, Suzuki Y, Suzuki T. (2007). Binding kinetics of infuenza viruses to sialic acid-containing carbohydrates. Glycoconj J, 24, 583-90. (Pubitemid 350030799)
41. Hinshaw VS, Webster RG, Easterday BC, Bean WJ Jr. (1981). Replication of avian infuenza A viruses in mammals. Infect. Immun., 34, 354-61. (Pubitemid 12117530)
42. Hirst GK. (1941). The agglutination of red cells by allantoic fuid of chick embryos infected with infuenza virus. Science, 94, 22-3.
43. Huang RTC, Lichtenberg B, Rick O. (1996). Involvement of annexin V in the entry of infuenza viruses and role of phospholipids in infection. FEBS Letters, 392, 59-62. (Pubitemid 26268332)
44. Ibricevic A, Pekosz A, Walter MJ, Newby C, Battaile JT, Brown EG, Holtzman MJ, Brody SL. (2006). Infuenza virus receptor specifcity and cell tropism in mouse and human airway epithelial cells. J Virol, 80, 7469-80. (Pubitemid 44092569)
45. Ilver D, Johansson P, Miller-Podraza H, Nyholm PG, Teneberg S, Karlsson KA. (2003). Bacterium-host protein-carbohydrate interactions. Methods Enzymol, 363, 134-57. (Pubitemid 37270610)
46. Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, Castrucci MR, Donatelli I, Kida H, Paulson JC, Webster RG, Kawaoka Y. (1998). Molecular basis for the generation in pigs of infuenza A viruses with pandemic potential. J Virol, 72, 7367-73. (Pubitemid 28377868)
47. Ito T, Suzuki Y, Mitnaul L, Vines A, Kida H, Kawaoka Y. (1997a). Receptor specifcity of infuenza A viruses correlates with the agglutination of erythrocytes from diferent animal species. Virology, 227, 493-9. (Pubitemid 27241043)
48. Ito T, Suzuki Y, Suzuki T, Takada A, Horimoto T, Wells K, Kida H, Otsuki K, Kiso M, Ishida H, Kawaoka Y. (2000). Recognition of N-Glycolylneuraminic Acid Linked to Galactose by the alpha 2,3 Linkage Is Associated with Intestinal Replication of Infuenza A Virus in Ducks. J Virol, 74, 9300-5.
49. Ito T, Suzuki Y, Takada A, Kawamoto A, Otsuki K, Masuda H, Yamada M, Suzuki T, Kida H, Kawaoka Y. (1997b). Diferences in sialic acid-galactose linkages in the chicken egg amnion and allantois infuence human infuenza virus receptor specifcity and variant selection. J Virol, 71, 3357-62. (Pubitemid 27121583)
50. Jeon SH, Kayhan B, Ben-Yedidia T, Arnon R. (2004). A DNA aptamer prevents infuenza infection by blocking the receptor binding region of the viral hemagglutinin. J Biol Chem, 279, 48410-9. (Pubitemid 39540998)
51. Jeong OM, Kim MC, Kim MJ, Kang HM, Kim HR, Kim YJ, Joh SJ, Kwon JH, Lee YJ. (2009). Experimental infection of chickens, ducks and quails with the highly pathogenic H5N1 avian infuenza virus. J Vet Sci, 10, 53-60.
52. Kida H, Ito T, Yasuda J, Shimizu Y, Itakura C, Shortridge KF, Kawaoka Y, Webster RG. (1994). Potential for transmission of avian infuenza viruses to pigs. J Gen Virol, 75, 2183-8. (Pubitemid 24282230)
53. Kim JA, Ryu SY, Seo SH. (2005). Cells in the respiratory and intestinal tracts of chickens have diferent proportions of both human and avian infuenza virus receptors. J Microbiol, 43, 366-9. (Pubitemid 41329721)
54. Kuchipudi S V, Nelli R, White GA, Bain M, Chang KC, Dunham S. (2009). Diferences in infuenza virus receptors in chickens and ducks: Implications for interspecies transmission. J Mol Genet Med, 3, 143-51.
55. Kuiken T, Fouchier R, Rimmelzwaan G, Osterhaus A, Roeder P. (2006a). Feline friend or potential foe? Nature, 440, 741-2.
56. Kuiken T, Holmes EC, McCauley J, Rimmelzwaan GF, Williams CS, Grenfell BT. (2006b). Host species barriers to infuenza virus infections. Science, 312, 394-7.
57. Kumari K, Gulati S, Smith DF, Gulati U, Cummings RD, Air GM. (2007). Receptor binding specifcity of recent human H3N2 infuenza viruses. Virol J, 4, 42.
58. Lackenby A, Hungnes O, Dudman SG, Meijer A, Paget WJ, Hay AJ, Zambon MC. (2008). Emergence of resistance to oseltamivir among infuenza A(H1N1) viruses in Europe. Euro Surveill, 13.
59. Leigh MW, Connor RJ, Kelm S, Baum LG, Paulson JC. (1995). Receptor specifcity of infuenza virus infuences severity of illness in ferrets. Vaccine, 13, 1468-73.
60. Lopez S, Arias CF. (2006). Early Steps in Rotavirus Cell Entry. In: ROY P, ed. Reoviruses: Entry, Assembly and Morphogenesis. New York: Springer Berlin Heidelberg, 39-66. (Pubitemid 47400273)
61. Maas R, Tacken M, Ruuls L, Koch G, van Rooij E, Stockhofe-Zurwieden N. (2007). Avian infuenza (H5N1) susceptibility and receptors in dogs. Emerg Infect Dis, 13, 1219-21. (Pubitemid 47359169)
62. Machytka D, Kharitonenkov I, Isecke R, Hetterich P, Brossmer R, Klein RA, Klenk H-D, Egge H. (1993). Methyl [alpha]-glycoside of N-thioacetyl-d- neuraminic acid: A potential inhibitor of infuenza A virus a 1H NMR study. FEBS Letters, 334, 117-20.
63. Maines TR, Chen LM, Matsuoka Y, Chen H, Rowe T, Ortin J, Falcon A, Nguyen TH, Mai le Q, Sedyaningsih ER, Harun S, Tumpey TM, Donis RO, Cox NJ, Subbarao K, Katz JM. (2006). Lack of transmission of H5N1 avian-human reassortant infuenza viruses in a ferret model. Proc Natl Acad Sci USA, 103, 12121-6. (Pubitemid 44215821)
64. Markwell MA, Paulson JC. (1980). Sendai virus utilizes specifc sialyloligosaccharides as host cell receptor determinants. Proc Natl Acad Sci USA, 77, 5693-7. (Pubitemid 11206383)
65. Marsh M, Pelchen-Matthews A. (1993). Entry of Animal Viruses into Cells. Rev Med Virol, 3, 173-85.
66. Matrosovich M, Stech J, Klenk HD. (2009). Infuenza receptors, polymerase and host range. Rev Sci Tech, 28, 203-17.
67. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. (2004). Human and avian infuenza viruses target diferent cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA, 101, 4620-4. (Pubitemid 38437460)
68. Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T. (2009). Inhibition of infuenza virus infections by sialylgalactose-binding peptides selected from a phage library. J Med Chem, 52, 4247-56.
69. Matsuoka Y, Lamirande EW, Subbarao K. (2009). The ferret model for infuenza. Curr Protoc Microbiol, Chapter 15, Unit 15G 2.
70. Mochalova L, Gambaryan A, Romanova J, Tuzikov A, Chinarev A, Katinger D, Katinger H, Egorov A, Bovin N. (2003). Receptor-binding properties of modern human infuenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs. Virology, 313, 473-80. (Pubitemid 37040687)
71. Nicholls JM, Bourne AJ, Chen H, Guan Y, Peiris JS. (2007a). Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian infuenza viruses. Respir Res, 8, 73.
72. Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, Kwong DL, Wong MP, Chui WH, Poon LL, Tsao SW, Guan Y, Peiris JS. (2007b). Tropism of avian infuenza A (H5N1) in the upper and lower respiratory tract. Nat Med, 13, 147-9.
73. Ning ZY, Luo MY, Qi WB, Yu B, Jiao PR, Liao M. (2009). Detection of expression of infuenza virus receptors in tissues of BALB/c mice by histochemistry. Vet Res Commun, 33, 895-903.
74. O'Brien TC, Tauraso NM. (1973). Antibodies to type A infuenza viruses in sera from nonhuman primates. Arch Gesamte Virusforsch, 40, 359-65.
75. Olofsson S, Bergstrom T. (2005). Glycoconjugate glycans as viral receptors. Ann Med, 37, 154-72. (Pubitemid 40780433)
76. Olofsson S, Kumlin U, Dimock K, Arnberg N. (2005). Avian infuenza and sialic acid receptors: more than meets the eye? Lancet Infect Dis, 5, 184-8. (Pubitemid 40568674)
77. Ottis K, Sidoli L, Bachmann PA, Webster RG, Kaplan MM. (1982). Human infuenza A viruses in pigs: isolation of a H3N2 strain antigenically related to A/England/42/72 and evidence for continuous circulation of human viruses in the pig population. Arch Virol, 73, 103-8. (Pubitemid 13246818)
78. Paulson JC. (1985). Interactions of animal viruses with cell surface receptors. In: Conn PM, ed. The Receptors. Orlando: Academic Press, 131-219.
79. Pensaert M, Ottis K, Vandeputte J, Kaplan MM, Bachmann PA. (1981). Evidence for the natural transmission of infuenza A virus from wild ducts to swine and its potential importance for man. Bull World Health Organ, 59, 75-8. (Pubitemid 11073209)
80. Perez DR, Lim W, Seiler JP, Yi G, Peiris M, Shortridge K F, Webster RG. (2003). Role of quail in the interspecies transmission of H9 infuenza A viruses: molecular changes on HA that correspond to adaptation from ducks to chickens. J Virol, 77, 3148-56. (Pubitemid 36228099)
81. Rigoni M, Tofan A, Viale E, Mancin M, Cilloni F, Bertoli E, Salomoni A, Marciano S, Milani A, Zecchin B, Capua I, Cattoli G. (2010). The mouse model is suitable for the study of viral factors governing transmission and pathogenesis of highly pathogenic avian infuenza (HPAI) viruses in mammals. Vet. Res., 41, 66.
82. Salomon R, Webster RG. (2009). The Infuenza Virus Enigma. Cell, 136, 402-10.
83. Sauter NK, Hanson JE, Glick GD, Brown JH, Crowther RL, Park SJ, Skehel JJ, Wiley DC. (1992). Binding of infuenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. Biochemistry, 31, 9609-21.
84. Schauer R. (2004). Sialic acids: fascinating sugars in higher animals and man. Zoology, 107, 49-64. (Pubitemid 40427891)
85. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. (2006). Avian fu: infuenza virus receptors in the human airway. Nature, 440, 435-6.
86. Sidwell RW, Smee D F. (2004). Experimental disease models of infuenza virus infections: recent developments. Drug Discovery Today: Disease Models, 1, 57-63. (Pubitemid 41123779)
87. Skehel JJ, Wiley DC. (2000). Receptor binding and membrane fusion in virus entry: the infuenza hemagglutinin. Annu Rev Biochem, 69, 531-69.
88. Snyder MH, London WT, Tierney EL, Maassab HF, Murphy BR. (1986). Restricted replication of a cold-adapted reassortant infuenza A virus in the lower respiratory tract of chimpanzees. J Infect Dis, 154, 370-1.
89. Songserm T, Amonsin A, Jam-on R, Sae-Heng N, Pariyothorn N, Payungporn S, Teamboonlers A, Chutinimitkul S, Tanawongnuwech R, Poovorawan Y. (2006). Fatal avian infuenza A H5N1 in a dog. Emerg Infect Dis, 12, 1744-7. (Pubitemid 44674253)
90. Srinivasan A, Viswanathan K, Raman R, Chandrasekaran A, Raguram S, Tumpey TM, Sasisekharan V, Sasisekharan R. (2008). Quantitative biochemical rationale for diferences in transmissibility of 1918 pandemic infuenza A viruses. Proc Natl Acad Sci USA, 105, 2800-5. (Pubitemid 351723624)
91. Stehle T, Harrison S. (1997). High-resolution structure of a polyomavirus VP1-oligosaccharide complex: implications for assembly and receptor binding. EMBO J, 16, 5139.
92. Stevens J, Blixt O, Glaser L, Taubenberger JK, Palese P, Paulson JC, Wilson IA. (2006a). Glycan microarray analysis of the hemagglutinins from modern and pandemic infuenza viruses reveals diferent receptor specifcities. J Mol Biol, 355, 1143-55. (Pubitemid 43012153)
93. Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA. (2006b). Structure and receptor specifcity of the hemagglutinin from an H5N1 infuenza virus. Science, 312, 404-10.
94. Stray SJ, Cummings RD, Air GM. (2000). Infuenza virus infection of desialylated cells. Glycobiology, 10, 649-58. (Pubitemid 30616200)
95. Suarez DL, Garcia M, Latimer J, Senne D, Perdue M. (1999). Phylogenetic analysis of H7 avian infuenza viruses isolated from the live bird markets of the Northeast United States. J Virol, 73, 3567-73. (Pubitemid 29189795)
96. Suzuki T, Horiike G, Yamazaki Y, Kawabe K, Masuda H, Miyamoto D, Matsuda M, Nishimura S-I, Yamagata T, Ito T, Kida H, Kawaoka Y, Suzuki Y. (1997). Swine infuenza virus strains recognize sialylsugar chains containing the molecular species of sialic acid predominantly present in the swine tracheal epithelium. FEBS Letters, 404, 192-6. (Pubitemid 27113451)
97. Suzuki Y, Ito T, Suzuki T, Holland RE, Jr., Chambers TM, Kiso M, Ishida H, Kawaoka Y. (2000). Sialic Acid Species as a Determinant of the Host Range of Infuenza A Viruses. J. Virol., 74, 11825-31. (Pubitemid 32222332)
98. Suzuki Y, Ito T, Suzuki T, Miyamoto D, Hidari KIPJ, Guo C-T, Kida H, Webster RG, Chambers TM, Kawaoka Y. (2001). Sialyl sugar chains as receptors and determinants of host range of infuenza A viruses. International Congress Series, 1219, 521-5.
99. Tavakkol A, Burness AT. (1990). Evidence for a direct role for sialic acid in the attachment of encephalomyocarditis virus to human erythrocytes. Biochemistry, 29, 10684-90.
100. Te Writing Committee of the World Health Organization Consultation on Human Infuenza A/H5. (2005). Avian Infuenza A (H5N1) Infection in Humans. N Engl J Med, 353, 1374-85.
101. Tiry E, Zicola A, Addie D, Egberink H, Hartmann K, Lutz H, Poulet H, Horzinek MC. (2007). Highly pathogenic avian infuenza H5N1 virus in cats and other carnivores. Vet Microbiol, 122, 25-31. (Pubitemid 46621079)
102. Tompson CI, Barclay WS, Zambon MC, Pickles RJ. (2006). Infection of human airway epithelium by human and avian strains of infuenza a virus. J Virol, 80, 8060-8. (Pubitemid 44182306)
103. Treichel U, Meyer zum Buschenfelde KH, Dienes HP, Gerken G. (1997). Receptor-mediated entry of hepatitis B virus particles into liver cells. Arch Virol, 142, 493-8. (Pubitemid 27161769)
104. Tumpey TM, Maines TR, Van Hoeven N, Glaser L, Solorzano A, Pappas C, Cox NJ, Swayne DE, Palese P, Katz JM, Garcia-Sastre A. (2007). A two-amino acid change in the hemagglutinin of the 1918 infuenza virus abolishes transmission. Science, 315, 655-9. (Pubitemid 46214711)
105. Van Der Laan JW, Herberts C, Lambkin-Williams R, Boyers A, Mann AJ, Oxford J. (2008). Animal models in infuenza vaccine testing. Expert Rev Vaccines, 7, 783-93.
106. Van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, Osterhaus AD, Kuiken T. (2006). H5N1 Virus Attachment to Lower Respiratory Tract. Science, 312, 399.
107. Van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RAM, Osterhaus ADME, Kuiken T. (2007). Human and Avian Infuenza Viruses Target Diferent Cells in the Lower Respiratory Tract of Humans and Other Mammals. Am J Pathol, 171, 1215-23. (Pubitemid 47582895)
108. Varki A. (2001a). Loss of N-glycolylneuraminic acid in humans: Mechanisms, consequences, and implications for hominid evolution. Am J Phys Anthropol, Suppl 33, 54-69.
109. Varki A. (2001b). N-glycolylneuraminic acid defciency in humans. Biochimie, 83, 615-22.
110. Varki A. (2008). Sialic acids in human health and disease. Trends Mol Med, 14, 351-60.
111. Varki NM, Varki A. (2007). Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest, 87, 851-7. (Pubitemid 47267816)
112. Vlasak R, Luytjes W, Spaan W, Palese P. (1988). Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of infuenza C viruses. Proc Natl Acad Sci USA, 85, 4526-9.
113. Wan H, Perez DR. (2006). Quail carry sialic acid receptors compatible with binding of avian and human infuenza viruses. Virology, 346, 278-86. (Pubitemid 43357872)
114. Weis W, Brown JH, Cusack S, Paulson JC, Skehel JJ, Wiley DC. (1988). Structure of the infuenza virus haemagglutinin complexed with its receptor, sialic acid. Nature, 333, 426-31.
115. White MR, Helmerhorst EJ, Ligtenberg A, Karpel M, Tecle T, Siqueira WL, Oppenheim FG, Hartshorn KL. (2009). Multiple components contribute to ability of saliva to inhibit infuenza viruses. Oral Microbiol Immunol, 24, 18-24.
116. Wickham TJ, Granados RR, Wood HA, Hammer DA, Shuler ML. (1990). General analysis of receptor-mediated viral attachment to cell surfaces. Biophysical Journal, 58, 1501-16.
117. Yamakawa T. (1996). A refection on the early history of glycosphingolipids. Glycoconj J, 13, 123-6.
118. Yao L, Korteweg C, Hsueh W, Gu J. (2008). Avian infuenza receptor expression in H5N1-infected and noninfected human tissues. FASEB J, 22, 733-40. (Pubitemid 351348126)
119. Yen HL, Lipatov AS, Ilyushina NA, Govorkova EA, Franks J, Yilmaz N, Douglas A, Hay A, Krauss S, Rehg JE, Hofmann E, Webster RG. (2007). Inefcient transmission of H5N1 infuenza viruses in a ferret contact model. J Virol, 81, 6890-8. (Pubitemid 46986625)
120. Yingsakmongkon S, Miyamoto D, Sriwilaijaroen N, Fujita K, Matsumoto K, Jampangern W, Hiramatsu H, Guo CT, Sawada T, Takahashi T, Hidari K, Suzuki T, Ito M, Ito Y, Suzuki Y. (2008). In vitro inhibition of human infuenza A virus infection by fruit-juice concentrate of Japanese plum (Prunus mume SIEB. et ZUCC). Biol Pharm Bull, 31, 511-5. (Pubitemid 351442138)
121. Youil R, Su Q, Toner TJ, Szymkowiak C, Kwan WS, Rubin B, Petrukhin L, Kiseleva I, Shaw AR, DiStefano D. (2004). Comparative study of infuenza virus replication in Vero and MDCK cell lines. J Virol Methods, 120, 23-31. (Pubitemid 38968653)
122. Zaitsev V, von Itzstein M, Groves D, Kiefel M, Takimoto T, Portner A, Taylor G. (2004). Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J Virol, 78, 3733-41. (Pubitemid 38568312)
123. Zhang H. (2008). Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic infuenza. J Antimicrob Chemother, 62, 219-23. (Pubitemid 351984763)